Nations Eyeing Gilead's Covid Drug Should Take Note Of Failed Trial: WHO.

NDTV News

NDTV.com provides latest news from India and the world. Get today’s news headlines from Business, Technology, Bollywood, Cricket, videos, photos, live news coverage and exclusive breaking news from India.

https://www.ndtv.com/

Nations Eyeing Gilead's Covid Drug Should Take Note Of Failed Trial: WHO

Gilead is allowing generic companies to manufacture the drug for supply to 127 low-income countries.

Geneva/Zurich:

Health officials reviewing Gilead Science Inc's remdesivir against COVID-19 should consider all evidence, including a trial in which the medicine failed, before giving it the green light, the top WHO scientist said on Friday.

US regulators appeared not to have done so when approving the drug this week, Soumya Swaminathan told a news conference.

The US Food and Drug Administration on Thursday approved Gilead's antiviral drug for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States.

The FDA decision came a week after the release of the results of the World Health Organization's Solidarity trial, which concluded remdesivir has little or no impact on a patient's chances of surviving COVID-19.

The FDA said its approval was based on three trials, including a 1,062-patient study by the National Institute of Allergy and Infectious Disease, which found that remdesivir reduced hospital stays to 10 days from 15 days, and helped reduce the risk of death in some patients who were receiving oxygen. The drug did not improve overall survival.

"The Solidarity results do not refute these findings of benefit to patients," the FDA said in a statement posted on its website.

Remdesivir is also approved for treatment of patients with severe COVID-19 in Japan, Taiwan, India, Singapore, the United Arab Emirates and the European Union. Gilead is allowing generic companies to manufacture the drug for supply to 127 low-income countries.

"We believe our results are very robust," the WHO's Swaminathan said, when asked about the FDA move. "We hope that people who are doing treatment guidelines in other countries, as well as regulators around the world, will take note of our study results, in addition to the other evidence."

For the remdesivir arm of the WHO's Solidarity trial, 2,743 patients were given the treatment, compared to 2,708 in the control group.

Newsbeep


Gilead, which has raised the possibility of bias in the "unblinded" WHO study because patients and their doctors were aware of which treatments were being used, got initial data from the trial in late September, the WHO has said.

"We have apprised FDA of the topline WHO Solidarity trial results and the draft manuscript" submitted to a publication, the company said. "However, at this time Gilead has not received the requested datasets from WHO for the Solidarity trial results."

The WHO also said on Friday that its formal guidelines on use of remdesivir for COVID-19 should be ready for release in three to four weeks, after a separate group within the United Nations health agency reviews data from the study.

An independent WHO panel will convene next week to look at all evidence of the effectiveness of Gilead's drug, Janet Diaz, the WHO's top official for clinical care responses, said.

"We would anticipate that the guidelines will be available within three to four weeks," Diaz said. "What we're doing now in the pandemic is to try to continue with that approach in a transparent and trustworthy way, but do it faster."

(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)

InternetUA Canon і Sony розробляють технологію «голограм» для онлайн-трансляцій. InternetUA Дві великі японські компанії в галузі електроніки Canon і Sony розробляють шляхи створення живих виступів і заходів за допомогою технології тривимірного відео нового рівня на тлі пандемії коронавірусу, яка ускладнює проведення заходів у реальному житті.
Багнет Зеленский заявил, кто первым получит вакцину от COVID-19. Багнет
Апостроф Все решит один фактор: озвучен прогноз по срокам завершения эпидемии COVID-19 в Украине. Апостроф Эпидемия коронавируса, которая не стихает в Украине, может пойти на спад только после того, как в стране начнется вакцинация против COVID-19.
Цензор.НЕТ В ряде стран Европы фиксируют рекордные показатели суточной смертности из-за COVID-19, однако темпы распространения инфекции снижаются. Цензор.НЕТ В ряде стран Европы фиксируют максимальные показатели суточной смертности среди инфицированных коронавирусом COVID-19, в то же время наблюдается снижение темпов распространения инфекции, в частности, во Франции и Великобритании.
Главком Львовские врачи показали, как выглядят легкие тяжелобольных Сovid-19. Главком «Это одни из самых страшных легких, которые я видела в жизни», – сказала руководитель реанимации
Related news

China weighs creating list of ‘diehard’ Taiwan supporters for future legal action.

Taiwan condemned the plan for the list, which reportedly could include senior Taiwanese government officials.

1 4

Donald Trump Plans To Pardon Former Aide Michael Flynn: Report.

US President Donald Trump plans to pardon his former national security advisor Michael Flynn, who pleaded guilty in 2017 to lying to the FBI over his Russian contacts, US media reported Tuesday.

6 10

Trump, aides have discussed plans to pardon Michael Flynn: reports.

A person familiar with discussions between Trump and his aides told The New York Times that the Republican president plans to pardon Flynn before leaving office. 

3 28

US To Distribute 6.4 Million Covid Vaccine Doses In First Tranche

The United States plans to distribute 6.4 million doses of the Pfizer-BioNTech Covid-19 vaccine in the first week after it is cleared for emergency use, which is likely next month, officials said...

4 7

Champagne, Conservative foreign affairs critic Michael Chong spar over China approach.

The Conservative foreign affairs critic told Champagne during a House of Commons committee meeting Tuesday that the government needs to show Canadians how it will deal with growing Chinese intimidation of Canadians within Canada's borders.

3 2

Lebanon Judge Wants Ministers Investigated Over Port Blast.

The judge leading Lebanon's probe into the deadly Beirut port blast wants three members of the cabinet investigated over their possible responsibility in the disaster, a judicial source said Tuesday.

3 2

2 New York police officers shot during domestic violence call, suspected shooter dead.

Rondell Goppy, 41, walked into his Queens home and started shooting around 12:45 p.m., just minutes after the officers arrived there with a woman who had gone to their police station to report an assault, Shea said.

7 233

Nevada certifies Biden win, approving state’s final U.

The court action drew extra scrutiny amid legal efforts by the state GOP and Trump campaign to prevent sending vote-by-mail ballots to all 1.82 million active registered voters and then to stop the counting of the 1.4 million votes that were cast.

5 64

Saying «America Is Back,» Biden Presents Security And Foreign Policy Team.

President-elect Joe Biden on Tuesday introduced a slate of veteran diplomats and policy-makers who will make up his national security and foreign policy team, saying: "America is back, ready to lead...

5 6

Trump vows to continue fight to overturn election results as Biden transition begins.

An administration official said logistics on when and where Biden will first receive the briefing were still being worked out.

5